concept
lysosom
cellular
compart
degrad
biolog
macromolecul
set
place
semin
work
de
duve
repres
foundat
modern
cell
biolog
fact
lysosom
compart
provid
perfect
home
hydrolyt
enzym
stabl
show
greatest
activ
within
acid
interior
lysosom
hand
lysosom
membran
lock
destruct
enzym
within
lysosom
vesicl
thu
provid
protect
cellular
compart
among
hydrolas
acid
cellular
compart
multipl
peptidebond
cleav
proteas
socal
cathept
activ
deriv
greek
mean
digest
boil
initi
discov
acid
gastric
juic
follow
tradit
mani
primarili
intracellular
proteas
exhibit
optim
proteolyt
activ
acidifi
vesicl
ie
classic
lysosom
endosom
multivesicular
bodi
acid
secretori
vesicl
name
cathepsin
howev
today
cathepsin
classifi
base
structur
catalyt
type
serin
cathepsin
g
aspart
cathepsin
e
cystein
cathepsin
latter
constitut
largest
cathepsin
famili
proteas
human
annot
clan
ca
famili
cathepsin
b
f
h
k
l
w
v
zx
complic
matter
lysosom
compart
contain
addit
proteas
name
cathepsin
aspart
proteas
napsin
relat
cathepsin
e
cystein
proteas
asparagin
endopeptidas
aep
also
name
legumain
clan
cd
famili
recent
interest
noncanon
physiolog
patholog
function
cytosol
nucleu
even
mitochondria
establish
almost
lysosom
proteas
cathepsin
also
found
secret
extracellular
milieu
proteas
often
contribut
pathogenesi
diseas
arthriti
cancer
howev
regard
de
duve
focu
review
recent
work
concern
specif
function
individu
serin
cystein
aspartatetyp
acid
proteas
also
combin
network
action
lysosom
howev
longer
stand
alon
organel
complex
mechan
regul
biogenesi
lysosom
deliveri
degradationpron
substrat
lumen
organel
henc
organ
discuss
cathepsin
function
along
main
deliveri
rout
lysosom
ie
endoand
phagocytosi
well
autophagi
pathway
endocyt
pathway
provid
set
dynam
biochem
special
endomembran
structur
physic
commun
plasma
membran
highli
flexibl
scaffold
mediat
precis
spatiotempor
control
transport
divers
biolog
signal
fig
earli
endosom
ph
first
station
along
endocyt
pathway
receiv
vesicl
type
deriv
cell
surfac
contain
instanc
intern
plasma
membran
receptor
earli
endosom
ph
mani
ligand
dissoci
receptor
eg
egf
egfr
subsequ
recycl
cell
surfac
late
endosom
acid
ph
ph
receiv
intern
materi
earli
endosom
phagosom
newli
synthes
molecul
transgolgi
network
transport
substanc
final
destin
lysosom
ph
proteas
contain
acid
cellular
compart
play
multipl
essenti
role
divers
task
endolysosom
protein
degrad
protein
process
main
function
endolysosom
compart
modul
termin
signal
transduct
pathway
dissoci
growth
factor
receptor
subsequ
degrad
andor
recycl
plasma
membran
report
cathepsin
b
respons
degrad
epiderm
growth
factor
egf
liver
well
degrad
intern
egf
receptor
complex
studi
insulinlik
growth
factori
igfi
identifi
anoth
target
endolysosom
degrad
furthermor
inhibit
cystein
proteas
compound
cell
permeabl
specif
cathepsin
b
alter
receptor
traffick
signal
sever
tumor
cell
line
treatment
lysosom
proteas
inhibitor
also
led
inhibit
lysosom
degrad
igfi
abrog
igfi
receptor
signal
reduct
igfi
receptor
level
cell
surfac
earlier
group
shown
treatment
cancer
cell
gener
cystein
cathepsin
inhibitor
block
invas
decreas
liver
metastasi
later
demonstr
proteas
respons
igfi
degrad
cathepsin
b
howev
cathepsin
b
proteas
implic
select
growth
factor
degrad
exampl
aspart
proteas
cathepsin
identifi
respons
endosom
degrad
insulin
two
major
primari
end
product
cathepsin
l
defici
fibroblast
insulinlik
growth
factor
bind
protein
accumul
cultur
medium
due
decreas
intracellular
degrad
furthermor
prolifer
primari
keratinocyt
cathepsin
l
null
mice
hyperrespons
egf
stimul
trace
fate
radioact
label
egf
keratinocyt
reveal
cathepsin
l
defici
cell
exhibit
enhanc
recycl
intact
growth
factor
medium
plasma
membran
fig
addit
shown
treatment
medium
condit
cathepsin
l
defici
keratinocyt
result
higher
keratinocyt
prolifer
medium
cultur
wildtyp
keratinocyt
studi
reveal
activ
number
posit
regul
downregul
inhibitor
growth
factor
signal
pathway
cathepsin
l
defici
keratinocyt
fact
shown
vivo
level
activ
ra
significantli
elev
skin
cathepsin
l
null
mice
hyperact
ra
central
mani
cancerpromot
signal
process
mapkinas
aktpkb
pathway
agreement
pathway
found
activ
cathepsin
l
defici
keratinocyt
well
activ
akt
phosphoryl
enhanc
upon
incub
cathepsin
l
defici
cell
medium
condit
cathepsin
l
defici
keratinocyt
support
autocrin
akt
stimul
caus
absenc
proteas
find
fit
observ
made
mous
model
skin
cancer
loss
cathepsin
l
surprisingli
lead
enhanc
tumor
phenotyp
summar
fig
data
suggest
impair
degrad
enhanc
recycl
plasma
membran
receptor
ligand
absenc
cathepsin
l
result
increas
prolifer
basal
keratinocyt
turn
lead
epiderm
hyperprolifer
period
hair
loss
cathepsin
l
defici
mice
addit
sustain
oncogen
physiolog
condit
receptor
recycl
plasma
membran
transport
vesicl
tv
howev
major
receptor
well
egf
termin
transport
lysosom
ly
degrad
shut
signal
cascad
cathepsin
l
defici
keratinocyt
receptorligand
complex
taken
normal
transport
ee
le
compart
loss
proteas
howev
lead
reduc
degrad
receptor
ligand
ly
consequ
enhanc
recycl
egf
receptor
notabl
intact
egf
tv
plasma
membran
result
increas
egf
signal
transduct
indic
red
arrow
henc
increas
cell
prolifer
activ
endolysosom
proteas
defici
endolysosom
proteas
dimer
egf
receptor
two
egf
molecul
signal
keratinocyt
cathepsin
l
defici
skin
cancer
mice
result
overal
aggrav
progress
tumor
taken
togeth
lysosom
cathepsin
play
import
role
bulk
protein
degrad
degrad
growth
factor
receptor
also
involv
receptortraffick
signal
ldl
receptor
bind
apolipoprotein
cholesterolrich
ldl
particl
result
endocytosi
ldlreceptor
complex
deliveri
endolysosom
ldl
dissoci
receptor
cholesterol
releas
cell
membran
synthesi
steroidogenesi
bile
acid
synthesi
ldl
receptor
recycl
plasma
membran
subsequ
cycl
endocytosi
result
decreas
cholesterol
level
blood
ldl
receptor
express
regul
intracellular
cholesterol
level
mutat
either
ldl
receptor
ligand
apolipoprotein
result
decreas
abil
cell
import
cholesterol
caus
hypercholesterolemia
subsequ
cardiovascular
diseas
earli
work
suggest
proteas
respons
lysosom
ldl
degrad
might
endolysosom
cathepsin
b
van
lenten
et
al
show
primarili
cathepsin
cleav
apolipoprotein
b
normal
condit
propos
accumul
cholesteryl
ester
macrophag
atherosclerosi
might
due
fact
high
concentr
ldl
number
ldlreceptor
complex
reach
compart
hydrolysi
ratelimit
cathepsin
also
identifi
relev
proteas
degrad
anoth
complex
ldlreceptor
famili
name
tissuetyp
plasminogen
activatorplasminogen
activ
complex
highli
import
regul
fibrinolysi
demonstr
complex
intern
human
monocyt
via
member
ldl
receptor
famili
follow
degrad
cathepsin
deliveri
lysosom
later
shown
macrophag
well
intim
smooth
muscl
cell
atheroma
contain
abund
immunoreact
cystein
cathepsin
k
contribut
ecm
remodel
due
elastinolyt
collagenolyt
activ
proteas
upregul
upon
stimul
atheromaassoci
inflammatori
cytokin
subsequ
studi
involv
cathepsin
atherosclerosi
demonstr
mice
doubl
defici
cathepsin
ldl
receptor
mous
model
lack
cathepsin
reduc
atherosclerosi
week
atherogen
diet
addit
week
author
work
propos
sever
mechan
explain
result
contribut
secret
cathepsin
proteolysi
elast
lamina
ecm
basement
membran
blood
vessel
therebi
disturb
vessel
structur
integr
addit
suggest
alter
immun
respons
due
defect
antigen
present
foami
macrophag
recent
mechan
link
macrophag
cathepsin
b
l
atherosclerosi
propos
experi
reveal
impair
inflammatori
respons
intraperiton
inject
cholesterol
crystal
mice
defici
either
compon
inflammasom
cathepsin
b
cathepsin
l
propos
pathway
involv
lysosom
damag
uptak
cholesterol
crystal
macrophag
consequ
cathepsin
releas
cytosol
activ
inflammasom
yet
unknown
mechan
caspas
activ
activ
inflammasom
select
process
proinflammatori
hallmark
inflammatori
micromilieu
propag
atherosclerot
lesion
acid
cellular
compart
crucial
major
histocompat
complex
mhc
class
ii
mediat
antigen
present
antigen
present
cell
apc
protein
taken
extracellular
space
process
antigen
peptid
endosom
proteas
within
acid
environ
late
endosom
compart
also
call
mhc
class
ii
compart
furthermor
mhc
class
ii
protein
complex
direct
endoplasm
reticulum
er
late
endosom
compart
proteolyt
matur
order
present
newli
gener
antigen
peptid
cell
surfac
apc
present
self
antigen
peptid
mhc
class
ii
molecul
exclus
featur
apc
dendrit
cell
dc
macrophag
b
cell
apc
effici
take
materi
extracellular
space
phagocytosi
pinocytosi
receptormedi
endocytosi
shown
fig
ingest
materi
direct
endosom
compart
protein
get
process
degrad
acid
proteas
eg
cathepsin
peptid
gener
enzym
subsequ
present
cell
surfac
mhc
class
ii
molecul
activ
posit
helper
cell
case
exogen
pathogen
dc
potent
apc
abil
migrat
lymph
node
activ
foster
adapt
immun
respons
therefor
import
antigen
peptid
remain
preserv
dc
rather
becom
destroy
agreement
demonstr
dc
regul
endosom
ph
activ
nadph
oxidas
whose
product
alkalin
ph
therefor
limit
antigen
degrad
acid
proteas
furthermor
immunogen
protein
highli
depend
suscept
endolysosom
proteas
enhanc
protein
degrad
lead
strong
attenu
adapt
immun
respons
identif
antigen
peptid
specif
gener
destroy
one
particular
proteas
howev
difficult
result
function
redund
endolysosom
proteas
asparagin
endopeptidas
aep
also
call
legumain
exampl
propos
degrad
autoantigen
myelin
basic
protein
mbp
peptid
human
epstein
barr
virustransform
ebv
b
cell
line
therebi
remov
peptid
repertoir
induc
toler
self
antigen
thymu
contrast
anoth
studi
use
cell
line
differ
aep
inhibitor
chang
cell
respons
mbp
peptid
detect
howev
claim
cell
neutrophil
serin
proteas
cathepsin
g
taken
human
b
lymphoblast
cell
via
endocytosi
degrad
mbp
contrast
peptid
degrad
aep
specif
cleav
microbi
tetanu
toxin
antigen
present
via
mhc
class
ii
molecul
murin
well
human
b
cell
line
line
inhibit
aep
activ
mutat
aep
cleavag
site
tetanu
toxin
antigen
led
reduct
cell
respons
antigen
peptid
recent
howev
immun
aep
defici
mice
tetanu
toxin
antigen
show
differ
endpoint
analys
immun
respons
comparison
wt
mice
henc
aep
appear
dispens
present
antigen
tetanu
toxin
peptid
murin
dc
although
activ
might
acceler
kinet
present
tetanu
toxin
antigen
besid
aep
endolysosom
cathepsin
aspart
cathepsin
e
well
cystein
type
cathepsin
intens
scrutini
regard
peptid
gener
mhc
class
ii
mediat
antigen
present
shown
exogen
materi
select
target
cathepsin
human
dc
might
due
earli
fusion
phagosom
vesicl
mhc
class
ii
compart
predominantli
contain
proteolyt
activ
cathepsin
shown
primari
murin
apc
howev
term
peptid
gener
mhc
class
ii
present
evid
nonredund
role
cathepsin
apc
quit
limit
thu
deciph
contribut
singl
endolysosom
proteas
gener
destruct
antigen
peptid
might
elus
vari
accord
combin
proteas
express
within
particular
cell
type
studi
use
proteas
defici
mous
model
shown
cathepsin
cystein
proteas
cathepsin
b
dispens
antigen
present
consist
find
transplant
cathepsin
defici
bone
marrow
irradi
mice
caus
impair
immun
respons
chimera
two
differ
antigen
comparison
wt
mice
howev
chemic
inhibit
genet
ablat
cathepsin
actual
result
enhanc
present
antigen
peptid
deriv
myoglobin
known
cathepsin
substrat
set
myoglobin
process
residu
aspart
proteolyt
activ
assign
cathepsin
e
henc
pictur
emerg
cathepsin
degrad
protein
substrat
complet
structur
relat
cathepsin
e
gener
peptid
suffici
mhc
class
ii
present
primarili
destruct
role
cathepsin
antigen
present
demonstr
abil
initi
degrad
renal
goodpastur
autoantigen
specif
isoform
type
iv
collagen
caus
goodpastur
diseas
degrad
goodpastur
autoantigen
major
self
epitop
destroy
provid
reason
explan
goodpastur
autoreact
cell
escap
neg
cell
select
process
within
thymu
henc
subtl
balanc
peptid
gener
protein
degrad
mhc
class
ii
compart
utmost
import
proper
antigen
present
activ
cytotox
cell
depend
present
endogen
peptid
bound
mhc
class
molecul
almost
cell
type
bodi
peptid
mainli
gener
proteasom
cytosol
transport
tap
transport
associ
antigen
process
er
apc
howev
abl
present
foreign
exogen
peptid
mhc
class
molecul
via
tapdepend
tapindepend
pathway
process
gener
term
cross
present
although
tapindepend
vacuolar
cross
present
mechan
still
insuffici
understood
reason
assum
endolysosom
proteas
play
role
instanc
extracellular
portion
transmembran
protein
turn
lumen
endolysosom
aspart
cathepsin
contribut
mhc
class
present
antigen
peptid
deriv
transmembran
protein
addit
cathepsin
process
ovalbumin
influenza
viru
antigen
subsequ
peptid
present
mhc
class
molecul
vivo
restrict
tapindepend
mhc
class
cross
present
recent
experi
present
endocytos
hen
egg
white
lysozym
deriv
peptid
reveal
cathepsin
depend
cross
present
mhc
class
occur
earli
endosom
compart
late
endosom
compart
target
peptid
sole
mhc
class
ii
complex
fig
illustr
endolysosom
proteas
respons
gener
antigen
peptid
process
antigen
present
also
involv
invari
chain
proteolyt
process
endolysosom
proteas
extracellular
bacteria
taken
phagocytosi
transport
earli
endosom
ee
also
name
phagosom
late
endosom
compart
within
compart
antigen
protein
complex
degrad
variou
endolysosom
proteas
antigen
peptid
newli
gener
antigen
peptid
load
bind
groov
mhc
class
ii
molecul
le
complex
rout
cell
surfac
transport
vesicl
tv
subsequ
present
helper
cell
initi
adapt
immun
respons
cathepsin
defici
apc
mhc
class
ii
molecul
reach
le
transgolgi
network
previous
describ
howev
invari
chain
incomplet
process
within
le
lead
block
peptid
bind
groov
antigen
peptid
insuffici
load
onto
mhc
class
ii
molecul
turn
result
transport
cell
surfac
reduc
present
antigen
peptid
helper
cell
furthermor
defici
singl
endolysosom
proteas
ie
aep
lead
reduct
repertoir
antigen
peptid
gener
le
present
mhc
class
ii
molecul
final
result
impair
immun
respons
normal
induc
particular
antigen
peptid
activ
endolysosom
proteas
defici
endolysosom
proteas
mhc
class
ii
molecul
invari
chain
antigen
peptid
bacteriumpathogenantigen
protein
matur
mhc
class
ii
molecul
respect
process
mhc
class
ii
invari
chain
ii
ii
serv
chaperon
mhc
class
ii
molecul
prevent
undesir
peptid
bind
bind
groov
target
mhc
class
ii
molecul
endolysosom
compart
ii
get
process
review
complet
remov
ii
mhc
class
ii
molecul
allow
access
antigen
peptid
bind
groov
essenti
proper
antigen
present
helper
cell
initi
cleavag
ii
suggest
execut
leupeptininsensit
proteas
regard
aep
propos
initi
proteas
iiprocess
howev
aepdefici
mice
show
impair
iiprocess
combin
leupeptin
select
inhibitor
aep
aepi
lead
slight
delay
format
earli
process
ii
intermedi
human
ebvtransform
b
cell
line
delay
could
observ
use
aepi
alon
indic
aep
perform
initi
cleavag
step
ii
process
cascad
proteolyt
activ
endolysosom
serin
cystein
proteas
inhibit
moreov
aep
activ
differ
cell
line
cell
type
lead
hypothesi
first
cleavag
event
ii
process
depend
repertoir
activ
proteas
present
within
cell
although
involv
aspart
proteas
initi
ii
process
claim
use
recent
discov
aspart
proteas
inhibitor
grassystatin
pepstatin
cathepsin
defici
cell
reveal
chang
cell
respons
distinct
antigen
therefor
precis
definit
proteolyt
network
initi
ii
process
particular
cell
type
need
investig
addit
sequenti
process
ii
leav
small
iideriv
peptid
name
clip
class
ii
associ
invari
chain
peptid
bound
mhc
class
ii
bind
groov
mainli
perform
cathepsin
predominantli
express
apc
mice
defici
cathepsin
show
accumul
ii
degrad
product
apc
depend
high
affin
mhc
class
ii
molecul
clip
fragment
endoproteas
cathepsin
l
perform
ii
process
step
cortic
thymic
epitheli
cell
ctec
lead
reduc
helper
cell
number
cathepsin
l
defici
mice
due
disturb
posit
select
thymu
consid
express
pattern
result
function
analys
mice
like
cathepsin
v
human
orthologu
murin
cathepsin
l
import
process
human
thymu
interestingli
splice
variant
ii
abl
bind
activ
site
cathepsin
l
isol
well
cathepsin
l
human
kidney
homogen
bevec
et
al
show
dosedepend
inhibit
proteolyt
activ
cathepsin
l
subsequ
becam
clear
act
chaperon
cathepsin
l
apc
therebi
stabil
activ
form
within
endocyt
compart
well
extracellular
space
comparison
human
murin
system
reveal
similar
interact
characterist
cathepsin
l
speci
taken
togeth
current
understand
mhc
class
ii
invari
chain
proteolysi
reveal
extens
cooper
endolysosom
proteas
crucial
immunolog
process
endolysosom
compart
perfectli
equip
effici
sens
presenc
phagocytos
pathogen
set
inflammatori
respons
socal
pattern
recognit
receptor
prr
toll
like
receptor
tlr
famili
name
also
presum
express
intracellularli
endolysosom
compart
recogn
doubl
strand
ds
rna
encod
genom
virus
human
bind
singl
strand
ss
rna
wherea
ligand
compris
dna
piec
unmethyl
cpg
motif
characterist
bacteria
dna
virus
activ
nucleic
acidspecif
tlr
result
activ
promin
inflammatori
transcript
factor
consequ
secret
proinflammatori
cytokin
review
howev
intracellular
tlr
also
activ
host
nucleic
acid
vertebr
dna
pack
liposom
activ
enter
endolysosom
compart
henc
compartment
necessari
separ
self
stimuli
tlr
receptor
order
avoid
autoimmun
nonself
tlr
stimuli
reliabl
induc
cellular
defens
respons
activ
restrict
endolysosom
compart
reagent
block
acidif
shut
receptor
signal
addit
shown
process
proteas
deliveri
endolysosom
compart
full
length
process
form
receptor
abl
bind
ligand
process
form
receptor
recruit
adapt
protein
essenti
downstream
signal
ewald
et
al
unabl
block
process
use
broad
spectrum
inhibitor
cathepsin
ie
pepstatin
leupeptin
raw
mous
macrophag
cell
line
howev
park
et
al
inhibit
receptor
process
tlr
cell
line
use
cystein
cathepsin
inhibitor
zfafmk
simultan
target
cathepsin
l
select
inhibitor
ie
clik
lhv
respect
significantli
decreas
respons
ligand
cpg
suggest
major
role
promin
immun
proteas
cathepsin
l
process
discrep
two
report
conceiv
process
assign
action
singl
proteas
rather
sever
endolysosom
proteas
may
abl
execut
process
context
specif
manner
consist
hypothesi
signal
also
impair
cathepsin
k
defici
dc
reduc
level
process
form
found
aep
defici
cell
howev
mani
virus
sens
intracellular
tlr
virus
probabl
coevolut
endolysosom
compart
use
host
proteolyt
machineri
compart
escap
cytosol
via
fusion
viral
envelop
endosom
membran
shown
endolysosom
process
glycoprotein
ebola
viru
ebov
critic
deliveri
viral
materi
cytosol
occur
predominantli
action
cathepsin
b
minor
extent
cathepsin
l
addit
chemic
inhibit
genet
ablat
cathepsin
b
reveal
proteolyt
process
ebov
glycoprotein
cathepsin
b
prerequisit
infect
vero
cell
vesicular
stomat
viru
express
ebov
glycoprotein
furthermor
endoproteas
cathepsin
l
function
uncoat
factor
reoviru
disassembl
convert
virion
infecti
subvirion
particl
murin
fibroblast
cathepsin
l
also
essenti
infect
cell
sar
sever
acut
respiratori
syndrom
coronaviru
cleav
glycoprotein
viru
therebi
mediat
membran
fusion
summari
endolysosom
proteas
play
contradictori
role
infect
good
side
involv
sens
infect
strengthen
cellular
defens
howev
proteas
also
support
sever
viru
type
carri
rather
deathli
action
catabol
reaction
occur
endolysosom
compart
critic
maintain
cellular
homeostasi
failur
degrad
macromolecul
contain
compart
result
accumul
caus
first
malfunct
compart
subsequ
failur
cell
tissu
function
clearli
evidenc
lysosom
storag
disord
group
rare
inherit
diseas
singl
defici
lysosom
enzym
caus
sever
defect
skelet
develop
myopathi
movement
disord
dementia
often
prematur
death
complementari
degrad
extracellularand
plasma
membranederiv
macromolecul
endocyt
pathway
alreadi
describ
previou
section
cell
also
employ
conserv
regul
turnov
longliv
intracellular
protein
organel
lysosom
degrad
gener
known
autophagi
pathway
subdivid
three
distinct
process
mammalian
cell
name
macroautophagi
fig
microautophagi
chaperonemedi
autophagi
eukaryot
cell
autophagi
basal
level
constitut
present
cell
perform
housekeep
function
degrad
protein
destruct
dysfunct
organel
fusion
autophag
vacuol
lysosom
subsequ
degrad
content
lysosom
enzym
crucial
correct
execut
macroautophagi
well
conceiv
endolysosom
proteas
play
import
role
degrad
regul
event
autophag
process
excel
review
role
lysosom
lysosom
proteas
apoptot
autophag
cell
death
recent
publish
therefor
aspect
lysosom
cathepsin
discuss
articl
one
proteas
shown
critic
chaperon
mediat
autophagi
cma
protect
proteincathepsin
ppca
serin
carboxypeptidas
cuervo
colleagu
provid
evid
lysosomeassoci
membran
protein
type
substrat
ppca
function
receptor
chaperon
mediat
autophagi
one
three
splice
variant
gene
singlespan
lysosom
membran
protein
highli
nglycosyl
lumin
domain
protein
prone
cma
specif
bind
cytoplasm
domain
lead
multimer
trigger
transloc
substrat
lysosom
subsequ
disassembl
transloc
complex
mediat
chaperon
whole
cma
process
bind
cma
substrat
protein
limit
step
level
regul
mainli
de
novo
synthesi
chang
stepwis
degrad
within
discret
microdomain
cours
process
cleavag
cytosol
portion
yet
unidentifi
metalloproteas
follow
cleavag
ppca
lumin
side
lead
releas
truncat
form
rapidli
degrad
lysosom
proteas
cell
defect
ppca
show
reduc
rate
degrad
higher
level
higher
rate
cma
restor
ppca
proteas
activ
reduc
level
cma
rate
clearli
indic
crucial
role
ppca
cma
therebi
mani
physiolog
process
cma
implic
cellular
respons
oxid
stress
age
immun
respons
gener
cell
homeostasi
congenit
neuron
ceroidlipofuscinosi
ncl
neurodegen
diseas
character
progress
psychomotor
retard
blind
prematur
death
due
accumul
lipopigmentslipofuscin
neuron
cell
mani
organ
includ
liver
spleen
myocardium
kidney
year
et
al
discov
genet
form
ncl
sheep
caus
defici
lysosom
aspart
proteas
cathepsin
point
mutat
led
convers
activ
site
aspart
asparagin
result
stabl
yet
enzymat
inact
protein
later
screen
patient
ncl
reveal
mutat
cathepsin
gene
result
inact
enzym
mutat
cathepsin
gene
lead
protein
reduc
proteolyt
activ
lower
level
cathepsin
patient
fibroblast
also
link
earli
onset
ncl
disord
character
earli
blind
progress
psychomotor
impair
fig
cathepsin
macroautophagi
cellular
homeostasi
process
macroautophagi
dysfunct
organel
mitochondria
enclos
doubl
membran
socal
isol
membran
im
subsequ
autophagosom
ap
form
ap
fusion
lysosom
ly
result
autophagolysosom
apli
ap
cargo
degrad
healthi
cell
small
residu
bodi
rb
remain
lack
critic
proteas
activ
lysosom
ie
cathepsin
cathepsin
l
defici
primarili
impair
im
apli
format
howev
case
proteas
defici
materi
enclos
autophagolysosom
degrad
result
accumul
unusu
larg
vesicl
ie
apli
defect
termin
autophag
process
pathomechan
lysosom
storag
may
impair
tissu
function
eventu
caus
cell
death
turn
result
clinic
relev
lysosom
storag
disord
activ
endolysosom
proteas
defici
endolysosom
proteas
mitochondrion
deleteri
effect
insuffici
cathepsin
also
observ
cathepsin
defici
mice
display
phenotyp
character
sever
gener
hypotrophi
neurodegener
includ
intracellular
accumul
autophag
vesicl
similar
ceroidlipofuscinosi
die
shortli
birth
neuron
cell
death
model
mediat
mitochondria
ie
independ
proapotot
famili
member
bax
howev
level
autophagosom
marker
increas
suggest
cell
death
neurodegener
cathepsin
defici
mediat
alter
macroautophagylysosom
degrad
pathway
result
demonstr
import
lysosom
proteas
cellular
homeostasi
especi
tissu
low
regener
rate
heart
muscl
neuron
surpris
defici
cathepsin
cathepsin
also
link
defect
macroautophagi
exampl
cathepsin
bl
doubl
defici
mice
develop
lethal
neurodegener
accumul
autophagosom
vesicl
brain
tissu
similar
phenotyp
observ
cathepsin
defici
anim
mice
defici
cystein
endoproteas
cathepsin
l
show
multipl
complex
phenotyp
strikingli
phenotyp
cardiomyopathi
hair
loss
impair
gener
thyroid
hormon
frequent
associ
unusu
larg
vesicl
variou
cell
type
tissu
affect
loss
proteas
instanc
increas
amount
low
densiti
vesicl
high
level
lysosom
marker
detect
myocardium
cathepsin
l
defici
mice
cardiomyocyt
specif
reexpress
cathepsin
l
otherwis
cathepsin
l
defici
anim
suffici
normal
vesicular
organ
cell
significantli
improv
myocardi
function
furthermor
proteom
analysi
cathepsin
l
defici
heart
reveal
increas
level
mani
mitochondri
protein
togeth
impair
mitochondri
respir
macroautophagi
repres
major
pathway
remov
age
dysfunct
organel
mitochondria
therefor
hypothes
cell
defect
cathepsin
l
may
also
defect
autophag
remov
mitochondria
autophagi
gener
recent
address
use
cathepsin
l
defici
mous
embryon
fibroblast
model
system
howev
initi
autophagi
format
autophagosom
respons
nutrient
depriv
rapamycin
treatment
significantli
alter
cathepsin
l
defici
cell
contrast
cathepsin
l
defici
caus
accumul
larg
autophagolysosom
indic
impair
degrad
autophagocytos
materi
thu
prohibit
correct
termin
autophagi
interestingli
proteas
appear
compens
loss
cathepsin
l
shift
endolysosom
proteolyt
system
new
homeostat
balanc
enough
function
compat
life
reproduct
previou
studi
provid
evid
increas
protein
level
lysosom
aspart
proteas
cathepsin
upon
cathepsin
l
downregul
thyroid
epitheli
cell
find
confirm
cathepsin
l
defici
fibroblast
elev
level
cathepsin
also
detect
brain
cathepsin
bl
doubl
defici
mice
discuss
previou
section
cathepsin
well
cathepsin
bl
doubl
defici
mous
model
develop
sever
neurodegen
disord
thu
appear
cathepsin
l
togeth
cathepsin
b
major
proteas
involv
turnov
intracellular
organel
ie
autophagolysosom
variou
tissu
fig
also
seem
true
human
cathepsin
l
transgen
express
human
proteas
cathepsin
bl
doubl
defici
background
rescu
neurodegener
lethal
mice
previou
section
abl
present
part
evid
support
endolysosom
proteas
execut
individu
specif
decis
function
mani
import
cellular
process
much
current
knowledg
obtain
genomewid
proteas
gene
discoveri
combin
genet
studi
employ
knockdown
knockout
transgen
overexpress
strategi
less
progress
achiev
biochem
analysi
proteolyt
event
within
endolysosom
compart
due
fact
compart
consist
multitud
intracellular
vesicl
dynam
chang
actual
state
cell
therefor
difficult
isol
puriti
satisfactori
mani
instanc
situat
prevent
identif
specif
proteas
substrat
hinder
understand
compensatori
network
proteas
acid
cellular
compart
sinc
novel
technolog
hand
tempor
spatial
resolv
monitor
endolysosom
proteas
activ
detect
specif
proteas
cleavag
site
within
substrat
might
next
address
challeng
proteas
investig
de
duve
lysosom
